Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis
Author(s) -
Amit K. Dey,
Ranjitha Gaddipati,
Youssef Elnabawi,
Emily L. Ongstad,
Aditya Goyal,
Jonathan H. Chung,
Heather Teague,
Justin Rodante,
Aparna Sajja,
Alexander V. Sorokin,
Sundus S. Lateef,
Milena Aksentijevich,
Harry Choi,
Aarthi Reddy,
Nevin Varghese,
Jacob Groenendyk,
Agastya D. Belur,
Leonard Genovese,
Joshua Rivers,
Joseph B. Lerman,
Mohammad Tarek Kabbany,
Charlotte Harrington,
Jenis Ortiz,
Noor Khalil,
Andrew Keel,
Yvonne Baumer,
Marcus Y. Chen,
David A. Bluemke,
Aditya A. Joshi,
Mariana J. Kaplan,
Alan T. Remaley,
Martin P. Playford,
Sotirios K. Karathanasis,
Joel M. Gelfand,
Ruchi Gupta,
Nehal N. Mehta
Publication year - 2019
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2019.3595
Subject(s) - medicine , psoriasis , interquartile range , coronary artery disease , cardiology , lipoprotein , cohort , gastroenterology , dermatology , cholesterol
Psoriasis, a chronic inflammatory skin disease associated with accelerated noncalcified coronary burden (NCB) by coronary computed tomography angiography (CCTA), accelerates lipoprotein oxidation in the form of oxidized modified lipoproteins. A transmembrane scavenger receptor for these oxidized modified lipoproteins is lectinlike oxidized low-density lipoprotein receptor-1 (LOX-1), which has been reported to be associated with coronary artery disease. It is unknown whether this receptor is associated with coronary artery disease in psoriasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom